A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis

NCT05095246 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Pandemic, logistical, and recruitment challenges

Conditions

Interventions

Sponsor

Krystal Biotech, Inc.

Collaborators